整体生态系统战略,以促进生物制药初创企业的成功
Beatrice Bader1, Maximillian Zinner1, Hubert Trübel2
1Faculty of Health, Witten/Herdecke University, Witten, Germany.
Trends in biotechnology
|December 20, 2025
概括
生物制药初创公司通过当地生态系统推动创新. 一个新的框架详细介绍了五个关键支柱 - - 网络,技术转让,资金,教育和文化 - - 以促进繁荣的生物制药集群和加速药物开发.
科学领域:
- 生物制药领域的创新
- 集群发展集群的发展.
- 创新生态系统创新生态系统
背景情况:
- 生物制药初创公司对于推动制药创新至关重要.
- 这些初创公司依赖于强大的本地生态系统,这些生态系统整合了关键参与者,资源和支持因素.
- 了解这些生态系统的组成部分对于促进增长至关重要.
研究的目的:
- 综合现有的文献和专家对生物制药集群发展的见解.
- 为建立和增强生物制药创新生态系统提出一个全面的框架.
- 引导决策者和利益相关者加速生物制药创新.
主要方法:
- 文学综合 文学综合
- 专家洞察力汇编专家洞察力汇编
- 发展框架 发展框架
主要成果:
- 确定生物制药集群成功的五个关键支柱:网络,技术转让,资金,教育和文化.
- 提出了一个结构化的框架,以指导繁荣的生物制药集群的发展.
- 该框架强调了创新生态系统中各种元素的相互联系.
结论:
- 拟议的五大支柱框架为决策者和利益相关者提供了一份路线图,以培养成功的生物制药集群.
- 加强这些支柱可以显著加快制药创新的步伐.
- 有效的集群发展对于生物制药行业的持续增长和竞争力至关重要.
更多相关视频
相关概念视频
Biopharmaceutical Factors Influencing Drug Product Design: Overview
218
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
218
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Bioremediation
22.0K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
22.0K
Drug Products: Biologics, Biosimilars and Interchangeables
217
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
217
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
152
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
152


